17-05-2025
Craig-Hallum Sticks to Its Buy Rating for scPharmaceuticals (SCPH)
Craig-Hallum analyst Chase Knickerbocker reiterated a Buy rating on scPharmaceuticals (SCPH – Research Report) on May 15 and set a price target of $12.00. The company's shares closed yesterday at $3.22.
Confident Investing Starts Here:
Quickly and easily unpack a company's performance with TipRanks' new KPI Data for smart investment decisions
Receive undervalued, market resilient stocks straight to you inbox with TipRanks' Smart Value Newsletter
Knickerbocker covers the Healthcare sector, focusing on stocks such as Ironwood Pharma, Harrow Health, and MiMedx Group. According to TipRanks, Knickerbocker has an average return of 3.3% and a 43.33% success rate on recommended stocks.
The word on The Street in general, suggests a Strong Buy analyst consensus rating for scPharmaceuticals with a $16.50 average price target, which is a 412.42% upside from current levels. In a report released on May 15, H.C. Wainwright also reiterated a Buy rating on the stock with a $18.00 price target.
